Systemische JIA mit Polyarthritis nach einer Kawasaki-Erkrankung

• Literatur

• 1 Neudorf U, Lilienthal E, Hospach T. Handlungsempfehlung nach der Leitlinie „Vaskulitiden - Kawasaki-Syndrom“. Monatszeitschrift Kinderheilkunde 2014; 162: 435-437.
• 2 Dong S, Bout-Tabaku S, Texter K, Jaggi P. Diagnosis of Systemic-Onset Juvenile Idiopathic Arthritis after Treatment for Presumed Kawasaki Disease. J Pediatr 2015; 166: 1283-1288.
• 3 Takahara T, Shimizu M, Nakagishi Y. et al. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease; Rheumatol Int. 2015; 35: 81-84.
• 4 Kudela H, Drynda S, Lux A. et al. Interleukin-18 (IL-18) as a Biomarker for Diagnosis and Evaluation of Disease Activity in Patients with Adult Onset Still’s Disease and Systemic Onset Juvenile Idiopathic Arthritis. Arthritis Rheumatol 2015. 67: (suppl 10)
• 5 Wittkowski H, Frosch M, Foell D. S100A12 is a Novel Molecular Marker Differentiating Systemic Onset Juvenile Idiopathic Arthritis from other Causes of Fever of Unknown Origin. Arthritis Rheum 2008; 58 (12) 3924-3931.
• 6 Holzinger D, Frosch M, Kastrup A. et al. The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Ann Rheum Dis 2012; 71 (06) 974-980.